Skip to main content
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Subscribe
Chase Doyle
Authored Items
Applying CAR T-Cell Therapies to Solid Tumors: Overcoming Current Challenges
By
Chase Doyle
Articles
Web Exclusives
,
Immunotherapy
Read More ›
Dual-Specific CAR T-Cell Therapy Targets CD19 and CD22 in Patients with Acute Lymphoblastic Leukemia
By
Chase Doyle
Articles
Web Exclusives
,
Immunotherapy
Read More ›
Combining Immunotherapy and Radiotherapy Shows Good Synergy
By
Chase Doyle
Articles
Web Exclusives
,
Immunotherapy
Read More ›
Which Combination Immunotherapies to Use, and When? High Response Rates, but Serious Toxicity Remains a Concern
By
Chase Doyle
Articles
Web Exclusives
,
Immunotherapy
Read More ›
Recent FDA Approvals for ALL a “Watershed” Moment
By
Chase Doyle
Articles
Web Exclusives
,
Leukemia
Read More ›
Daratumumab Added to Carfilzomib, Lenalidomide, and Dexamethasone: Safe and Tolerable in Patients with Newly Diagnosed Multiple Myeloma
By
Chase Doyle
Articles
Web Exclusives
,
Multiple Myeloma
Read More ›